跳转至内容
Merck
CN

GW22309F

Sigma-Aldrich

Anti-CDK4 antibody produced in chicken

affinity isolated antibody, buffered aqueous solution

登录查看公司和协议定价

选择尺寸


关于此项目

MDL编号:
UNSPSC代码:
12352203
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

生物来源

chicken

偶联物

unconjugated

抗体形式

affinity isolated antibody

抗体产品类型

primary antibodies

克隆

polyclonal

表单

buffered aqueous solution

种属反应性

mouse, rat, human

制造商/商品名称

Genway 15-288-22309F

技术

western blot: suitable

NCBI登记号

UniProt登记号

运输

wet ice

储存温度

−20°C

靶向翻译后修饰

unmodified

基因信息

human ... CDK4(1019)

免疫原

Immunogen Sequence: GI # 4502735, sequence 1-303
Recombinant cyclin-dependent kinase 4

应用

Anti-CDK4 antibody produced in chicken is suitable for western blotting analysis at a dilution of 1:500, for tissue or cell staining at a dilution of 1:200.

生化/生理作用

Cyclin-dependent kinase 4 (also known as cell division protein kinase 4) is an enzyme encoded by the CDK4 gene in humans. It is highly expressed in nasopharyngeal carcinomas (NPC). CDK4 phosphorylates and inactivates retinoblastoma (Rb) protein family members in association with cyclin-D. It mediates progression through the G1- to the S-phase of the cell cycle. Over expression of CDK4 is mostly independent with gene amplification and is a potential prognostic biomarker in NPC and may indicate tumor aggressiveness through cell cycle dysregulation. It is the main molecular feature of well-differentiated liposarcomas (WDLS) and dedifferentiated liposarcomas (DDLS). Inhibition of CDK4 partly restores G(1)-S arrest and sensitizes cells to doxorubicin-mediated cell death in MYCN-amplified cells with an intact p53 pathway. CDK4 up-regulation takes place in oral cancer progression.

外形

Solution in phosphate buffered saline containing 0.02% sodium azide.

未找到合适的产品?  

试试我们的产品选型工具.

储存分类代码

12 - Non Combustible Liquids

WGK

WGK 1

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Tzu-Ju Chen et al.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 35(7), 7209-7216 (2014-04-29)
Data mining in the public domain demonstrates that cyclin-dependent kinase 4 (CDK4) is highly expressed in nasopharyngeal carcinomas (NPC). Associated with cyclin-D, CDK4 phosphorylates and inactivates retinoblastoma (Rb) protein family members and mediates progression through the G1- to the S-phase
Sina Gogolin et al.
Cell cycle (Georgetown, Tex.), 12(7), 1091-1104 (2013-03-07)
Relapse with drug-resistant disease is the main cause of death in MYCN-amplified neuroblastoma patients. MYCN-amplified neuroblastoma cells in vitro are characterized by a failure to arrest at the G(1)-S checkpoint after irradiation- or drug-induced DNA damage. We show that several
Ming J Poi et al.
Anticancer research, 34(7), 3285-3292 (2014-07-02)
While aberrant expression of cyclin-dependent kinase-4 (CDK4) has been found in squamous cell carcinoma of the head and neck (SCCHN), the associations between CDK4 and its regulators, namely, cyclin D1, cyclin E, gankyrin, SEI1, and BMI1 in gene expression remain
Seung Eun Lee et al.
Histology and histopathology, 29(1), 127-138 (2013-07-16)
The amplification of MDM2 and CDK4 is the main molecular feature of well-differentiated liposarcomas (WDLS) and dedifferentiated liposarcomas (DDLS). Although the diagnostic usefulness of this molecular characteristic in liposarcomas has been investigated, its prognostic utility of quantitative gene level has

相关内容

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持